In fact, these stocks often have even more upside than better-established ones. The weight loss market could reach $150 ...

Viking Therapeutics is mispriced due to the successful but misunderstood clinical results of their oral GLP-1 treatment. Read ...

Makers of weight-loss drugs saw their stocks surge in 2024, but no more. Now Trump's price deal adds new questions. Is the ...

We’ve been writing about holidays afloat for years, having well and truly caught the cruise bug. We love the excitement of ...

Competition is heating up, but questions remain about insurance coverage, drug pricing, copycat drugs and the role of pills in the space.

Eli Lilly's next-gen obesity drugs, led by oral orforglipron and triple-acting retatrutide, aim to reshape the fast-growing ...

Vitamins and supplements have gained popularity in recent years, making it challenging to determine which ones are worth the investment. Learn which vitamins work and which ones to skip.

Vegan diets can increase the risk for several mineral deficiencies. Can you adopt a vegan diet without ever using supplements ...

Viking Global's $45 million investment in Metsera, a biotech company is caught in a bidding war between Pfizer and Novo ...

Dr. Ann Coulter of Pennington Biomedical Research Center recently presented research on a novel nutritional supplement that ...

Collagen. Probiotics. Every letter of vitamin under the sun. Your local drugstore is full of them—but how much do they actually do for you? Although dietary supplements have become a ...

In September 2025, the U.S. Food and Drug Administration (FDA) published its Unified Agenda of Federal Regulatory and Deregulatory Actions (Unified Agenda), which contains regulations that the FDA is ...